AN2 Therapeutics, Inc. - ANTX - Fundamentals

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	0	0	0	0	0	0	--	📊
Revenue Growth (1Y)	--	--	--	--	--	--	--	--	📊
Revenue Growth (5Y)	--	--	--	--	--	--	--	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	0	0	0	0	0	0	0	--	📊
Cost of Revenue Growth (1Y)	--	--	--	--	-100.00%	--	--	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	0	0	0	-0	0	0	0	--	📊
Gross Profit Growth (1Y)	--	--	--	--	+100.00%	--	--	--	📊
Gross Profit Growth (5Y)	--	--	--	--	--	--	--	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	5	7	22	42	70	55	38	39	📊
Operating Expenses Growth (1Y)	--	+40.67%	+196.18%	+95.89%	+64.77%	-21.66%	-30.14%	+1.84%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+1244.82%	+648.96%	+76.64%	+79.90%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	0	1	5	13	15	14	13	12	📊
Research and Development	5	6	17	30	55	40	25	27	📊
Other Income Expenses	0	-6	-0	-0	0	0	0	--	📊
EBITDA	0	-6	0	-42	5	-51	-38	-39	📊
EBITDA Growth (1Y)	--	--	+100.00%	--	+111.60%	-1146.73%	+25.74%	-3.64%	📊
EBITDA Growth (5Y)	--	--	--	--	--	-712.17%	--	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	31	7	22	0	70	0	0	--	📊
Operating Income	-5	-7	-22	-42	-70	-55	-38	-39	📊
Operating Income Growth (1Y)	--	-40.67%	-196.18%	-95.89%	-64.77%	+21.66%	+30.14%	-1.84%	📊
Operating Income Growth (5Y)	--	--	--	--	-1244.82%	-648.96%	-76.64%	-79.90%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	1	0	0	0	--	📊
Pre Tax Income	-6	-14	-22	-41	-65	-51	-35	-36	📊
Tax Provision	-0	-0	-0	1	0	0	0	--	📊
NET INCOME	-6	-14	-21	-41	-65	-51	-35	-36	📊
Net Income Growth (1Y)	--	-141.35%	-57.90%	-93.12%	-56.09%	+20.72%	+31.46%	-3.13%	📊
Net Income Growth (5Y)	--	--	--	--	-1048.75%	-277.36%	-63.80%	-68.93%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	-0.3	-0.73	-1.15	-2.14	-2.74	-1.72	-1.16	-1.07	📊
Diluted EPS	-0.3	-0.73	-1.15	-2.14	-2.74	0	-1.16	-1.07	📊
Basic Average Shares	19	19	19	19	24	30	30	35	📊
Diluted Average Shares	19	19	19	19	24	30	30	35	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

📊

Revenue Growth (5Y)

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

-100.00%

📊

Cost of Revenue Growth (5Y)

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-0

📊

Gross Profit Growth (1Y)

+100.00%

📊

Gross Profit Growth (5Y)

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+40.67%

+196.18%

+95.89%

+64.77%

-21.66%

-30.14%

+1.84%

📊

Operating Expenses Growth (5Y)

+1244.82%

+648.96%

+76.64%

+79.90%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

-6

-0

📊

EBITDA

-6

-42

-51

-38

-39

📊

EBITDA Growth (1Y)

+100.00%

+111.60%

-1146.73%

+25.74%

-3.64%

📊

EBITDA Growth (5Y)

-712.17%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-5

-7

-22

-42

-70

-55

-38

-39

📊

Operating Income Growth (1Y)

-40.67%

-196.18%

-95.89%

-64.77%

+21.66%

+30.14%

-1.84%

📊

Operating Income Growth (5Y)

-1244.82%

-648.96%

-76.64%

-79.90%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-6

-14

-22

-41

-65

-51

-35

-36

📊

Tax Provision

-0

📊

NET INCOME

-6

-14

-21

-41

-65

-51

-35

-36

📊

Net Income Growth (1Y)

-141.35%

-57.90%

-93.12%

-56.09%

+20.72%

+31.46%

-3.13%

📊

Net Income Growth (5Y)

-1048.75%

-277.36%

-63.80%

-68.93%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.3

-0.73

-1.15

-2.14

-2.74

-1.72

-1.16

-1.07

📊

Diluted EPS

-0.3

-0.73

-1.15

-2.14

-2.74

-1.16

-1.07

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Breakdown	2019 12/31	2020 12/31	2021 12/31	2022 12/31	2023 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	0	0	0	0	0	0	--	📊
Revenue Growth (1Y)	--	--	--	--	--	--	--	--	📊
Revenue Growth (5Y)	--	--	--	--	--	--	--	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue	0	0	0	0	0	0	0	--	📊
Cost of Revenue Growth (1Y)	--	--	--	--	-100.00%	--	--	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	--	--	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	📊
Gross Profit	0	0	0	-0	0	0	0	--	📊
Gross Profit Growth (1Y)	--	--	--	--	+100.00%	--	--	--	📊
Gross Profit Growth (5Y)	--	--	--	--	--	--	--	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	📊
Operating Expenses	5	7	22	42	70	55	38	39	📊
Operating Expenses Growth (1Y)	--	+40.67%	+196.18%	+95.89%	+64.77%	-21.66%	-30.14%	+1.84%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+1244.82%	+648.96%	+76.64%	+79.90%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	📊
Sell General Administrative	0	1	5	13	15	14	13	12	📊
Research and Development	5	6	17	30	55	40	25	27	📊
Other Income Expenses	0	-6	-0	-0	0	0	0	--	📊
EBITDA	0	-6	0	-42	5	-51	-38	-39	📊
EBITDA Growth (1Y)	--	--	+100.00%	--	+111.60%	-1146.73%	+25.74%	-3.64%	📊
EBITDA Growth (5Y)	--	--	--	--	--	-712.17%	--	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	📊
Depreciation and Amortization	31	7	22	0	70	0	0	--	📊
Operating Income	-5	-7	-22	-42	-70	-55	-38	-39	📊
Operating Income Growth (1Y)	--	-40.67%	-196.18%	-95.89%	-64.77%	+21.66%	+30.14%	-1.84%	📊
Operating Income Growth (5Y)	--	--	--	--	-1244.82%	-648.96%	-76.64%	-79.90%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Interest Expense	0	0	0	1	0	0	0	--	📊
Pre Tax Income	-6	-14	-22	-41	-65	-51	-35	-36	📊
Tax Provision	-0	-0	-0	1	0	0	0	--	📊
NET INCOME	-6	-14	-21	-41	-65	-51	-35	-36	📊
Net Income Growth (1Y)	--	-141.35%	-57.90%	-93.12%	-56.09%	+20.72%	+31.46%	-3.13%	📊
Net Income Growth (5Y)	--	--	--	--	-1048.75%	-277.36%	-63.80%	-68.93%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	📊
Basic EPS	-0.3	-0.73	-1.15	-2.14	-2.74	-1.72	-1.16	-1.07	📊
Diluted EPS	-0.3	-0.73	-1.15	-2.14	-2.74	0	-1.16	-1.07	📊
Basic Average Shares	19	19	19	19	24	30	30	35	📊
Diluted Average Shares	19	19	19	19	24	30	30	35	📊

Breakdown

2019

12/31

2020

12/31

2021

12/31

2022

12/31

2023

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

📊

Revenue Growth (5Y)

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

-100.00%

📊

Cost of Revenue Growth (5Y)

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

-0

📊

Gross Profit Growth (1Y)

+100.00%

📊

Gross Profit Growth (5Y)

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

+40.67%

+196.18%

+95.89%

+64.77%

-21.66%

-30.14%

+1.84%

📊

Operating Expenses Growth (5Y)

+1244.82%

+648.96%

+76.64%

+79.90%

📊

Operating Expenses Growth (10Y)

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

-6

-0

📊

EBITDA

-6

-42

-51

-38

-39

📊

EBITDA Growth (1Y)

+100.00%

+111.60%

-1146.73%

+25.74%

-3.64%

📊

EBITDA Growth (5Y)

-712.17%

📊

EBITDA Growth (10Y)

📊

Depreciation and Amortization

📊

Operating Income

-5

-7

-22

-42

-70

-55

-38

-39

📊

Operating Income Growth (1Y)

-40.67%

-196.18%

-95.89%

-64.77%

+21.66%

+30.14%

-1.84%

📊

Operating Income Growth (5Y)

-1244.82%

-648.96%

-76.64%

-79.90%

📊

Operating Income Growth (10Y)

📊

Interest Expense

📊

Pre Tax Income

-6

-14

-22

-41

-65

-51

-35

-36

📊

Tax Provision

-0

📊

NET INCOME

-6

-14

-21

-41

-65

-51

-35

-36

📊

Net Income Growth (1Y)

-141.35%

-57.90%

-93.12%

-56.09%

+20.72%

+31.46%

-3.13%

📊

Net Income Growth (5Y)

-1048.75%

-277.36%

-63.80%

-68.93%

📊

Net Income Growth (10Y)

📊

Basic EPS

-0.3

-0.73

-1.15

-2.14

-2.74

-1.72

-1.16

-1.07

📊

Diluted EPS

-0.3

-0.73

-1.15

-2.14

-2.74

-1.16

-1.07

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-10.09%
Next Earnings
Market cap	226.04M (USD)
EPS (TTM)	-1.07 ($)
P/E (TTM)	-4.72 ($)
Last Close	5.05

Next Earnings
Market cap	226.04M (USD)
EPS (TTM)	-1.07 ($)
P/E (TTM)	-4.72 ($)
Last Close	5.05 ($)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-10.09%
Next Earnings
Market cap	226.04M (USD)
EPS (TTM)	-1.07 ($)
P/E (TTM)	-4.72 ($)
Last Close	5.05

Next Earnings
Market cap	226.04M (USD)
EPS (TTM)	-1.07 ($)
P/E (TTM)	-4.72 ($)
Last Close	5.05 ($)